uluru inc (ULUR:OTC US)
uluru inc (ULUR) Snapshot
|
Open
$0.35
|
Previous Close
$0.35
|
|
|
Day High
$0.35
|
Day Low
$0.34
|
|
|
52 Week High
01/14/13 - $0.40
|
52 Week Low
06/29/12 - $0.16
|
|
|
Market Cap
5.0M
|
Average Volume 10 Days
34.9K
|
|
|
EPS TTM
$-0.37
|
Shares Outstanding
14.2M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
uluru inc (ULUR) Related Businessweek News
No Related Businessweek News Founduluru inc (ULUR) Details
ULURU Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of wound care and muco-adhesive film products in the United States and internationally. The company’s products are based on patented Nanoflex and OraDisc drug delivery technologies. Its products include Altrazeal, a transforming powder dressing for the treatment of various wounds, such as partial thickness burns, donor sites, and abrasions, as well as surgical, acute, and chronic wounds; Aphthasol and Aptheal for the treatment of canker sores; OraDisc A for the treatment of oral conditions, which rely upon the use of medications formulated as gels and pastes that are applied to lesions in the mouth; and OraDisc B, a muco-adhesive disc product for the treatment and management of oral pain. The company is based in Addison, Texas.
Last Reported Date: 03/29/13
uluru inc (ULUR) Top Compensated Officers
uluru inc (ULUR) Key Developments
ULURU Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company’s total revenues were $102,044 against $60,005 a year ago. Operating loss was $547,369 against $819,712 a year ago. Loss before income taxes was $656,590 against $843,409 a year ago. Net loss was $656,590 against $843,409 a year ago. Net loss allocable to common stockholders was $668,611 or $0.06 basic and diluted per share against $854,135 or $0.11 basic and diluted per share a year ago. The increase of $42,000 in revenues is primarily attributable to an increase of $55,000 in Altrazeal(R) product sales.
ULURU Inc., Q1 2013 Earnings Call, May 20, 2013
ULURU Inc. reported unaudited consolidated results for the fourth quarter and year ended December 31, 2012. For the quarter, the company’s total revenues were $165,456 against $255,527 a year ago. Operating loss was $868,803 against $839,206 a year ago. Loss before income taxes was $978,069 against $855,811 a year ago. Net loss was $978,069 against $855,811 a year ago. Net loss allocable to common stockholders was $990,357 or $0.10 basic and diluted per share against $859,736 or $0.13 basic and diluted per share a year ago. For the year, the company’s total revenues were $370,594 against $484,536 a year ago. Operating loss was $3,264,820 against $4,014,133 a year ago. Loss before income taxes was $3,531,349 against $4,070,092 a year ago. Net loss was $3,531,349 against $4,070,092 a year ago. Net loss allocable to common stockholders was $3,578,805 or $0.42 basic and diluted per share against $4,074,479 or $0.67 basic and diluted per share a year ago. For the fourth quarter 2013, the company projects cash flow positive by the fourth quarter of 2013. For the full year 2013, the company projects increase in revenues for 2013, and forecasts a significant improvement in operating results.
| Recently Viewed | |||
| ULUR:US | $0.35 USD | 0.00 | |
| Company | Last | Change |
| 3M Co | $111.77 USD | +0.05 |
| Church & Dwight Co Inc | $62.94 USD | -0.06 |
| Smith & Nephew PLC | 788.50 GBp | 0.00 |
| View Industry Companies | ||
Industry Analysis
ULUR
Industry Average
| Valuation | ULUR | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 9.0x |
|
| Price/Book | 2.1x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 6.9x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: May 20
Sponsored Financial Commentaries
Sponsored Links
To contact ULURU INC, please visit www.uluruinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








